09.11.16
Kaoshiung City, Taiwan
2016 Nonwovens Sales: $213 million
Key Personnel
C.S Huang, chairman; H.S. Huang, president; M. Yang, vice president; Sam Chang, vice president; Paul Cheng, general manager; Bernard Kerstens, commercial director, overseas business
Plants
Kaoshiung, Taiwan, Pinghu, China
Processes
Spunlace, thermal bond, air through bond, needlepunch
Major Markets
Hygiene, medical, wipes
Sales continued to climb following the adoption of China’s two-child policy for Nan Liu Enterprises. The Kaoshiung City, Taiwan-based nonwovens producer reported a sales increase of 8% to $213 million in 2016. While these results may seem impressive, the company is not fully satisfied. “There is still much more space for further growth. To have nonwoven production grow further investments in large-scale equipment are needed,” says commercial director Bernard Kerstens.
Recent investment from Nan Liu includes a new plant in Yancho, near to Kaohsiung, which covers an area of 100,000 square meters of which 80,000 will be space for construction. The area will be ready for construction in the first half of 2018. Nan Liu has not yet disclosed the type of technology in which they will be investing here. An announcement will follow in due time.
Kerstens says the new operation, which will inject a new sense of vitality into the company, will ultimately be expanded and will eventually add about $100 million in annual sales to the company’s turnover.
Within the spunlace market, in general, aggressive expansion has led to some imbalance between supply and demand, but growth in medical materials as well as other new applications for spunlace is righting this situation. As the need for spunlace continues to grow, Nan Liu will continue to expand its production capacity.
“Medical products are one of the key segments for Nan Liu,” Kerstens says. “We expect to be able to grow further with these medical products based on their high level of confirmation by the market of Nan Liu’s quality. At the same time we are also dedicated to developing other medical materials for high-tech areas.”
Nan Liu already operates the widest spunlace line in the world. This 6.2-meter-wide-line is able to offer a number of unique functions to help meet clients’ needs. It began operation in 2013.
In other expansion news, Nan Liu added air through bonded capabilities to its Pinghu factory and this investment has received such positive feedback. Nan Liu has already confirmed it will add another one next year. This will bring air through bonded capacity to 600 tons per month.
Currently about half of the company’s sales are conducted in China, but the company has its sites on other parts of Asia, like India. In 2016, the company began investing in the subcontinent, purchasing a land parcel where it will build a nonwovens plant and begin operation in late 2018.
The company has yet to disclose the type of technology in which the investment will be done. “A company must move forward, otherwise it will decline. The next investment plan is currently under preparation and an announcement will go out once confirmed,” Kerstens says.
2016 Nonwovens Sales: $213 million
Key Personnel
C.S Huang, chairman; H.S. Huang, president; M. Yang, vice president; Sam Chang, vice president; Paul Cheng, general manager; Bernard Kerstens, commercial director, overseas business
Plants
Kaoshiung, Taiwan, Pinghu, China
Processes
Spunlace, thermal bond, air through bond, needlepunch
Major Markets
Hygiene, medical, wipes
Sales continued to climb following the adoption of China’s two-child policy for Nan Liu Enterprises. The Kaoshiung City, Taiwan-based nonwovens producer reported a sales increase of 8% to $213 million in 2016. While these results may seem impressive, the company is not fully satisfied. “There is still much more space for further growth. To have nonwoven production grow further investments in large-scale equipment are needed,” says commercial director Bernard Kerstens.
Recent investment from Nan Liu includes a new plant in Yancho, near to Kaohsiung, which covers an area of 100,000 square meters of which 80,000 will be space for construction. The area will be ready for construction in the first half of 2018. Nan Liu has not yet disclosed the type of technology in which they will be investing here. An announcement will follow in due time.
Kerstens says the new operation, which will inject a new sense of vitality into the company, will ultimately be expanded and will eventually add about $100 million in annual sales to the company’s turnover.
Within the spunlace market, in general, aggressive expansion has led to some imbalance between supply and demand, but growth in medical materials as well as other new applications for spunlace is righting this situation. As the need for spunlace continues to grow, Nan Liu will continue to expand its production capacity.
“Medical products are one of the key segments for Nan Liu,” Kerstens says. “We expect to be able to grow further with these medical products based on their high level of confirmation by the market of Nan Liu’s quality. At the same time we are also dedicated to developing other medical materials for high-tech areas.”
Nan Liu already operates the widest spunlace line in the world. This 6.2-meter-wide-line is able to offer a number of unique functions to help meet clients’ needs. It began operation in 2013.
In other expansion news, Nan Liu added air through bonded capabilities to its Pinghu factory and this investment has received such positive feedback. Nan Liu has already confirmed it will add another one next year. This will bring air through bonded capacity to 600 tons per month.
Currently about half of the company’s sales are conducted in China, but the company has its sites on other parts of Asia, like India. In 2016, the company began investing in the subcontinent, purchasing a land parcel where it will build a nonwovens plant and begin operation in late 2018.
The company has yet to disclose the type of technology in which the investment will be done. “A company must move forward, otherwise it will decline. The next investment plan is currently under preparation and an announcement will go out once confirmed,” Kerstens says.
